Opthea Ltd.

Opthea Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.08
Market Cap
AUD183.32 M
Shares Outstanding
249.41 M
Public Float
208.51 M

Profile

Address
650 Chapel Street
South Yarra Victoria (VIC) 3141
Australia
Employees -
Website http://www.opthea.com
Updated 07/08/2019
Opthea Ltd. is engaged in developing biological therapeutics for cancer and other serious diseases. It is a biologics drug developer building on its significant intellectual property portfolio around Vascular Endothelial Growth Factor C and D angiogenic molecules and R3. The company focuses on vascular endothelial growth factors to develop truly novel therapies to extend and improve the lives of cancer sufferers.

Financials

View All
Created with Highcharts 5.0.14Opthea Ltd.Net Income. Fiscal year is July-June. All values AUD Thousands.3 9963 9965 3125 3126 5076 5076 1926 19216 90216 9022014201520162017201805k10k15k20k

Geoffrey Paul Kempler
Non-Executive Chairman
Megan Baldwin
Chief Executive Officer, Executive Director & MD